Lincoln Pharmaceuticals Ltd (NSE:LINCOLN) Share Price

Company Profile

Business description
Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin, analgesics, anesthetics, anti-pyretic, GIT products, vitamin-minerals, and iron preparations. Some of the key brands through which the company markets its products are; Rhino, Binafin, Kezolin, Hepalin, Progut, and Vomistat among others. Geographically, it carries out sales in India and outside India; generating key revenue from outside India.
Contact
Science City Road
Lincoln House
Behind Satyam Complex
Sola
AhmedabadGJ380060
IND
T: +91 7941078000
https://www.lincolnpharma.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
1,853

Recommended

This share is trading at the lowest price to fair value of the 14 companies on the list.

Angus Hewitt, CFA | 05 January 2026

Despite a surging share price a weakening competitive position causes a reassessment of our view.

Shane Ponraj, CFA | 05 January 2026

We believe these companies’ strong ESG management practices give them a long-term advantage.

Margaret Giles | 04 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,010.40	65.30	-0.72%
CAC 40	8,211.50	16.29	0.20%
DAX 40	24,868.69	329.35	1.34%
Dow JONES (US)	48,977.18	594.79	1.23%
FTSE 100	10,004.57	53.43	0.54%
HKSE	26,693.54	346.30	1.31%
NASDAQ	23,395.82	160.19	0.69%
Nikkei 225	52,191.58	358.78	0.69%
NZX 50 Index	13,657.86	70.63	0.52%
S&P 500	6,902.05	43.58	0.64%
S&P/ASX 200	8,697.70	73.60	-0.84%
SSE Composite Index	4,056.87	33.45	0.83%